Consensus statement on proton therapy for prostate cancer

the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group

doi:10.14338/IJPT-20-00031.1

Consensus statement on proton therapy for prostate cancer

the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.

Original language	English (US)
Pages (from-to)	1-16
Number of pages	16
Journal	International Journal of Particle Therapy
Volume	8
Issue number	2
DOIs	https://doi.org/10.14338/IJPT-20-00031.1
State	Published - Sep 1 2021

Keywords

Particle therapy
Prostate cancer
Proton therapy
Radiation therapy

ASJC Scopus subject areas

Atomic and Molecular Physics, and Optics
Radiology Nuclear Medicine and imaging

Access to Document

10.14338/IJPT-20-00031.1

Cite this

@article{c839e1301b7d4f34aaccf841cec6411f,

title = "Consensus statement on proton therapy for prostate cancer",

abstract = "Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.",

keywords = "Particle therapy, Prostate cancer, Proton therapy, Radiation therapy",

author = "{the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group} and Bryant, {Curtis M.} and Henderson, {Randal H.} and Nichols, {R. Charles} and Mendenhall, {William M.} and Hoppe, {Bradford S.} and Vargas, {Carlos E.} and Daniels, {Thomas B.} and Choo, {C. Richard} and Parikh, {Rahul R.} and Huan Giap and Slater, {Jerry D.} and Neha Vapiwala and William Barrett and Akash Nanda and Mishra, {Mark V.} and Seungtaek Choi and Liao, {Jay J.} and Mendenhall, {Nancy P.}",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = sep,

day = "1",

doi = "10.14338/IJPT-20-00031.1",

language = "English (US)",

volume = "8",

pages = "1--16",

journal = "International Journal of Particle Therapy",

issn = "2331-5180",

publisher = "Allen Press Inc.",

number = "2",

}

TY - JOUR

T1 - Consensus statement on proton therapy for prostate cancer

AU - the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group

AU - Bryant, Curtis M.

AU - Henderson, Randal H.

AU - Nichols, R. Charles

AU - Mendenhall, William M.

AU - Hoppe, Bradford S.

AU - Vargas, Carlos E.

AU - Daniels, Thomas B.

AU - Choo, C. Richard

AU - Parikh, Rahul R.

AU - Giap, Huan

AU - Slater, Jerry D.

AU - Vapiwala, Neha

AU - Barrett, William

AU - Nanda, Akash

AU - Mishra, Mark V.

AU - Choi, Seungtaek

AU - Liao, Jay J.

AU - Mendenhall, Nancy P.

PY - 2021/9/1

Y1 - 2021/9/1

N2 - Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.

AB - Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.

KW - Particle therapy

KW - Prostate cancer

KW - Proton therapy

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85119173344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85119173344&partnerID=8YFLogxK

U2 - 10.14338/IJPT-20-00031.1

DO - 10.14338/IJPT-20-00031.1

M3 - Article

C2 - 34722807

AN - SCOPUS:85119173344

SN - 2331-5180

VL - 8

SP - 1

EP - 16

JO - International Journal of Particle Therapy

JF - International Journal of Particle Therapy

IS - 2

ER -

Consensus statement on proton therapy for prostate cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this